These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34366337)

  • 1. Pilot Evaluation of the Unsupervised, At-Home Cogstate Brief Battery in ADNI-2.
    Edgar CJ; Siemers E; Maruff P; Petersen RC; Aisen PS; Weiner MW; Albala B;
    J Alzheimers Dis; 2021; 83(2):915-925. PubMed ID: 34366337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease.
    White JP; Schembri A; Prenn-Gologranc C; Ondrus M; Katina S; Novak P; Lim YY; Edgar C; Maruff P
    J Alzheimers Dis; 2023; 96(4):1781-1799. PubMed ID: 38007647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unsupervised Performance of the CogState Brief Battery in the Brain Health Registry: Implications for Detecting Cognitive Decline.
    Banh T; Jin C; Neuhaus J; Mackin RS; Maruff P; Stricker N; Weiner MW; Nosheny RL
    J Prev Alzheimers Dis; 2022; 9(2):262-268. PubMed ID: 35542999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative.
    Thomas KR; Eppig JS; Weigand AJ; Edmonds EC; Wong CG; Jak AJ; Delano-Wood L; Galasko DR; Salmon DP; Edland SD; Bondi MW;
    Alzheimers Dement; 2019 Apr; 15(4):561-569. PubMed ID: 30610833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Comparison of in Clinic and at Home Administration of the Cogstate Brief Battery and Demonstrated Practice Effects in the Mayo Clinic Study of Aging.
    Stricker NH; Lundt ES; Alden EC; Albertson SM; Machulda MM; Kremers WK; Knopman DS; Petersen RC; Mielke MM
    J Prev Alzheimers Dis; 2020; 7(1):21-28. PubMed ID: 32010922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engagement in online cognitive testing with the Cogstate brief battery among a multinational cohort of people with focal epilepsy.
    Pellinen J; Sillau S; Morrison C; Maruff P; O'Brien TJ; Penovich P; French J; Knupp KG; Meador KJ;
    Epilepsy Behav; 2024 Oct; 159():109953. PubMed ID: 39121756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease.
    Maruff P; Lim YY; Darby D; Ellis KA; Pietrzak RH; Snyder PJ; Bush AI; Szoeke C; Schembri A; Ames D; Masters CL;
    BMC Psychol; 2013; 1(1):30. PubMed ID: 25566378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unsupervised Online Paired Associates Learning Task from the Cambridge Neuropsychological Test Automated Battery (CANTAB®) in the Brain Health Registry.
    Ashford MT; Aaronson A; Kwang W; Eichenbaum J; Gummadi S; Jin C; Cashdollar N; Thorp E; Wragg E; Zavitz KH; Cormack F; Banh T; Neuhaus JM; Ulbricht A; Camacho MR; Fockler J; Flenniken D; Truran D; Mackin RS; Weiner MW; Nosheny RL
    J Prev Alzheimers Dis; 2024; 11(2):514-524. PubMed ID: 38374758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability, Validity, and User-Experience of Remote Unsupervised Computerized Neuropsychological Assessments in Community-Living 55- to 75-Year-Olds.
    Kochan NA; Heffernan M; Valenzuela M; Sachdev PS; Lam BCP; Fiatarone Singh M; Anstey KJ; Chau T; Brodaty H
    J Alzheimers Dis; 2022; 90(4):1629-1645. PubMed ID: 36314208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
    Crane PK; Carle A; Gibbons LE; Insel P; Mackin RS; Gross A; Jones RN; Mukherjee S; Curtis SM; Harvey D; Weiner M; Mungas D;
    Brain Imaging Behav; 2012 Dec; 6(4):502-16. PubMed ID: 22782295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.
    Toledo JB; Weiner MW; Wolk DA; Da X; Chen K; Arnold SE; Jagust W; Jack C; Reiman EM; Davatzikos C; Shaw LM; Trojanowski JQ;
    Acta Neuropathol Commun; 2014 Mar; 2():26. PubMed ID: 24602322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium.
    Frisoni GB; Henneman WJ; Weiner MW; Scheltens P; Vellas B; Reynish E; Hudecova J; Hampel H; Burger K; Blennow K; Waldemar G; Johannsen P; Wahlund LO; Zito G; Rossini PM; Winblad B; Barkhof F;
    Alzheimers Dement; 2008 Jul; 4(4):255-64. PubMed ID: 18631976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS).
    Lim YY; Jaeger J; Harrington K; Ashwood T; Ellis KA; Stöffler A; Szoeke C; Lachovitzki R; Martins RN; Villemagne VL; Bush A; Masters CL; Rowe CC; Ames D; Darby D; Maruff P
    Arch Clin Neuropsychol; 2013 Jun; 28(4):320-30. PubMed ID: 23552802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
    Sato K; Mano T; Ihara R; Suzuki K; Tomita N; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; Iwatsubo T; Toda T; Iwata A;
    J Alzheimers Dis; 2019; 68(2):777-788. PubMed ID: 30814351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affective Neuropsychiatric Symptoms as Early Signs of Dementia Risk in Older Adults.
    Jang JY; Ho JK; Blanken AE; Dutt S; Nation DA;
    J Alzheimers Dis; 2020; 77(3):1195-1207. PubMed ID: 32925031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries.
    Buckley RF; Sparks KP; Papp KV; Dekhtyar M; Martin C; Burnham S; Sperling RA; Rentz DM
    J Prev Alzheimers Dis; 2017; 4(1):3-11. PubMed ID: 29188853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cogstate Brief Battery: Cognition and the feigning of cognitive impairment in chronic pain.
    Lupu T; Braw Y; Sacher Y; Ratmansky M
    Appl Neuropsychol Adult; 2022; 29(6):1332-1343. PubMed ID: 33492175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ADNI4 Digital Study: A novel approach to recruitment, screening, and assessment of participants for AD clinical research.
    Miller MJ; Diaz A; Conti C; Albala B; Flenniken D; Fockler J; Kwang W; Sacrey DT; Ashford MT; Skirrow C; Weston J; Fristed E; Farias ST; Korecka M; Wan Y; Aisen PS; Beckett L; Harvey D; Lee EB; Petersen RC; Shaw LM; Okonkwo OC; Mindt MR; Weiner MW; Nosheny RL;
    Alzheimers Dement; 2024 Oct; 20(10):7232-7247. PubMed ID: 39219153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.